Skip to main content

Table 1 Demographic and clinicopathologic characteristics of the study population (n = 243)

From: Comparison of stage III mucinous and serous ovarian cancer: a case-control study

Characteristics MOC Serous EOC  
Values, n (%) Values, n (%) p
Age, y (median, range) 53.9 (18–77) 53.4 (28–81) 0.73
Menopausal status
 Postmenopausal 49 (60.5%) 98 (60.5%) 1.0
 Premenopausal 32 (39.5%) 64 (39.5%) 1.0
CA 125 (IU/ml) (median, range) 126 (4–4891) 514 (8–27,580) 0.022
Grade
 1 29 (35.8%) 58 (35.8%) 1.0
 2–3 52 (64.2%) 104 (64.2%) 1.0
Stage
 IIIA1 13 (16.1%) 26 (16.1%) 1.0
 IIIA2 6 (7.4%) 12 (7.4%) 1.0
 IIIB 13 (16%) 26 (16%) 1.0
 IIIC 49 (60.5%) 98 (60.5%) 1.0
Debulking
 Optimal 54 (66.7%) 108 (66.7%) 1.0
 Maximal 27 (33.3%) 54 (33.3%) 1.0
Ascites
 Present 42 (51.9%) 125 (77.2%) < 0.001
 Absent 39 (48.1%) 37 (22.8%)
Peritoneal Cytology
 Positive 61 (75.3%) 137 (84.6%) 0.114
 Negative 20 (24.7%) 25 (15.4%)
Number of LNs removed (median, range) 34 (19–96) 49 (21–203) < 0.001
 Pelvic LNs 24 (10–75) 32 (10–101) 0.003
 Para-aortic LNs 11 (5–54) 15 (5–102) < 0.001
Retroperitoneal LN metastases
 Present 21 (25.9%) 91 (56.2%) < 0.001
 Absent 60 (74.1%) 71 (43.8%)
Appendiceal Involvement
 Present 29 (35.8%) 59 (36.4%) 1.0
 Absent 52 (64.2%) 103 (63.6%)
Omental Involvement
 Present 61 (75.3%) 113 (69.8%) 0.451
 Absent 20 (24.7%) 49 (30.2%)
Peritoneal Involvement
 Present 57 (70.4%) 103 (63.6%) 0.318
 Absent 24 (29.6%) 59 (36.4%)
Status
 Alive 32 (39.5%) 112 (69.1%)  
 Dead 49 (60.5%) 50 (30.9%)  
Follow-up, months (median, range) 21 (1–216) 46 (1–121)  
  1. Abbreviations: n Number, LN Lymph node, y year, MOC Mucinous Ovarian Carcinoma, EOC Epithelial Ovarian Carcinoma, SD Standard Deviation